• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

About FDA

  • Print
  • Share
  • E-mail

University of Rochester Telemetric and Holter ECG Warehouse (THEW)

Striving to advance the field of cardiac safety, the THEW initiative is developed under an agreement with FDA for facilitating collaborative discussions between THEW members, and for leveraging resources to implement joint projects among FDA, UR, and other public and private stakeholders.  THEW is a publicly accessible data warehouse where scientists from academia, industry, and government can develop and test new computer algorithms related to quantitative electrocardiography.  Designed to inform cardiac safety and medical product development, the THEW enables access to unique data and tools to develop automatic ECG analysis algorithms. Current research projects aim at increasing QT measurement accuracy used in drug safety trials, which would result in smaller, faster, and therefore more cost- and time-effective drug development processes. Better ECG markers and high precision detection techniques will benefit all stakeholders by ensuring that unsafe drugs do not get to market, while reducing the chances of a "false positive" signal.